QiShenYiQi pill inhibits atherosclerosis by promoting reverse cholesterol transport PPARγ-LXRα/β-Abca1 pathway
Bibliographic Data
| ID | 22917456 |
|---|---|
| Authors | Jing Xie (0000-0001-8156-0322, Guizhou University), Li Peng (0000-0003-0016-2977, Guizhou University, corresponding author), Taotao Wang (0000-0002-6459-7139), Chengyong Yang (Guizhou University), Nanting Chen (0009-0008-8801-8518, Guizhou University), Xue Feng (0000-0003-0845-8000, Guizhou University), Tingchun Wu (Affiliated Hospital of Guizhou Medical University), Tao Xu (0000-0002-0501-6445, Affiliated Hospital of Guizhou Medical University), Yunzhi Chen (0000-0002-4546-5341, Guizhou University) |
| Year | 2023 |
| Volume | 315 |
| Pages | 116684 |
| Publication date | 2023-10-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2023.116684 |
| PMID | 37230281 |
| OpenAlex | W4377690920 |
| Language | EN |
| Citations received | 1 |
| References cited | 30 |
The anti-atherosclerotic mechanism of QSYQ was involved in inhibiting lipid phagocytosis and promoting reverse cholesterol transport, therefore reducing lipid deposition and inflammatory cells in plaque.
ABCA1 · Aorta · Aspirin · Biology · Cholesterol · Gene · Oil Red O · Randomized controlled trial · Biochemistry · Cancer, Lipids, and Metabolism · Cholesterol and Lipid Metabolism · Endocrinology · Internal Medicine · Medicine · Peroxisome Proliferator-Activated Receptors · Pharmacology
| Citations per year | 1 |
|---|---|
| Citation span | 2026 - 2026 (1) |
| Highly cited | No |